Do you make any modifications to your treatment plan for older patients undergoing prostate SBRT?

At UCLA, we do not make treatment modifications of prescription dose or change our dose constraints for OAR in our elderly patients (> 75 y.o.) undergoing prostate SBRT. We have not noticed a difference in toxicity in older patients. Admittedly, this has not been studied in our cohort of patients in...